177 related articles for article (PubMed ID: 32792552)
1. Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study.
Choi JS; Kim MH; Kim YC; Lim YH; Bae HJ; Kim DK; Park JY; Noh J; Lee JP
Sci Rep; 2020 Aug; 10(1):13715. PubMed ID: 32792552
[TBL] [Abstract][Full Text] [Related]
2. Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients.
Park JY; Kim MH; Han SS; Cho H; Kim H; Ryu DR; Kim H; Lee H; Lee JP; Lim CS; Kim KH; Joo KW; Kim YS; Kim DK;
PLoS One; 2015; 10(5):e0127240. PubMed ID: 25984790
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the Modified Charlson Comorbidity Index in Incident Peritoneal Dialysis Patients: A National Population-Based Approach.
Cho H; Kim MH; Kim HJ; Park JY; Ryu DR; Lee H; Lee JP; Lim CS; Kim KH; Oh KH; Joo KW; Kim YS; Kim DK
Perit Dial Int; 2017 1-2; 37(1):94-102. PubMed ID: 27605681
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities Can Predict Mortality of Kidney Transplant Recipients: Comparison With the Charlson Comorbidity Index.
Park JY; Kim MH; Bae EJ; Kim S; Kim DK; Joo KW; Kim YS; Lee JP; Kim YH; Lim CS
Transplant Proc; 2018 May; 50(4):1068-1073. PubMed ID: 29731067
[TBL] [Abstract][Full Text] [Related]
5. Recalibration and validation of the Charlson Comorbidity Index in acute kidney injury patients underwent continuous renal replacement therapy.
Lee J; Jung J; Lee J; Park JT; Jung CY; Kim YC; Kim DK; Lee JP; Shin SJ; Park JY
Kidney Res Clin Pract; 2022 May; 41(3):332-341. PubMed ID: 35172534
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea.
Lee S; Chang YJ; Cho H
BMC Med Res Methodol; 2021 Apr; 21(1):66. PubMed ID: 33836666
[TBL] [Abstract][Full Text] [Related]
7. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
Kim Y; Kim YJ; Cho WK
BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
[TBL] [Abstract][Full Text] [Related]
8. Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients.
Rattanasompattikul M; Feroze U; Molnar MZ; Dukkipati R; Kovesdy CP; Nissenson AR; Norris KC; Kopple JD; Kalantar-Zadeh K
Int Urol Nephrol; 2012 Dec; 44(6):1813-23. PubMed ID: 22134841
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a comorbidity scoring system for patients with cirrhosis.
Jepsen P; Vilstrup H; Lash TL
Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
[TBL] [Abstract][Full Text] [Related]
10. Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies.
Hall RE; Porter J; Quan H; Reeves MJ
BMC Health Serv Res; 2019 Dec; 19(1):930. PubMed ID: 31796024
[TBL] [Abstract][Full Text] [Related]
11. Comparative Performance of Comorbidity Measures in Predicting Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease.
Zhan ZW; Chen YA; Dong YH
Int J Chron Obstruct Pulmon Dis; 2020; 15():335-344. PubMed ID: 32103932
[TBL] [Abstract][Full Text] [Related]
12. The Neiman Imaging Comorbidity Index: Development and Validation in a National Commercial Claims Database.
Pelzl CE; Rosenkrantz AB; Rula EY; Christensen EW
J Am Coll Radiol; 2024 Jun; 21(6):869-877. PubMed ID: 38276924
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the Korea Dementia Comorbidity Index (KDCI): A nationwide population-based cohort study from 2002 to 2013.
Kim JH; Yoo KB; Lee Y
Arch Gerontol Geriatr; 2017 Sep; 72():195-200. PubMed ID: 28709115
[TBL] [Abstract][Full Text] [Related]
14. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
[TBL] [Abstract][Full Text] [Related]
15. Validation of a neurovascular comorbidities index for retrospective database analysis.
Newman WC; Kubilis PS; Hoh BL
J Neurosurg; 2018 Jan; 130(1):273-277. PubMed ID: 29372882
[TBL] [Abstract][Full Text] [Related]
16. Validity of the modified Charlson Comorbidity Index as predictor of short-term outcome in older stroke patients.
Denti L; Artoni A; Casella M; Giambanco F; Scoditti U; Ceda GP
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):330-6. PubMed ID: 25498734
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.
Chu YT; Ng YY; Wu SC
BMC Health Serv Res; 2010 May; 10():140. PubMed ID: 20507593
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Charlson comorbidity index, the modified Charlson comorbidity index, and the recipient risk score in prediction of the graft and patient survival among renal graft recipients: historical cohort in a single center.
Masoumi N; Ghaffari M; Asgari MA; Dadpour M
Int Urol Nephrol; 2023 Oct; 55(10):2447-2456. PubMed ID: 37368085
[TBL] [Abstract][Full Text] [Related]
19. Developing a Charlson Comorbidity Index for the American Indian Population Using the Epidemiologic Data from the Strong Heart Study.
Rogers P; Merenda C; Araojo R; Lee C; Lolic M; Zhang Y; Reese J; Malloy K; Wang D; Zou W; Xu J; Lee E
Res Sq; 2023 Sep; ():. PubMed ID: 37841866
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study.
Chan MC; Lin CH; Kou YR
Int J Chron Obstruct Pulmon Dis; 2016; 11():1053-9. PubMed ID: 27274227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
